INTRODUCTION
Central to metabolic homeostasis is the kinase, mammalian target of rapamycin (mTOR) that exists as two distinct complexes, mTORC1 and mTORC2 (Saxton and Sabatini, 2017) (Figure 1A) . While both complexes bind common partners through mTOR's middle and C-terminal domains, mTORC1 and mTORC2 are distinguished by unique N-terminal regulators that utilize similar and mutually exclusive binding strategies. mTORC1 is bound by regulatory associated protein of mTOR (Raptor) (Hara et al., 2002; Kim et al., 2002) and controls metabolic processes and protein synthesis rates in response to mitogenic cues and nutrient or energy availability (Saxton and Sabatini, 2017) . mTORC1 is activated by PI3K-mediated stimulation of Akt ( Figure 1A ). mTORC2 is bound by rapamycin-insensitive companion of mTOR (Rictor) and phosphorylates Akt at Ser 473 to stimulate its activity (Hresko and Mueckler, 2005; Sarbassov et al., 2004; Sarbassov et al., 2005) . As mTORC1 lies downstream of Akt, to prevent a continuous feed-forward loop, the mTORC1 substrate p70S6K suppresses mTORC2, while another mTORC1 substrate Grb10 suppresses PI3K signaling (Hsu et al., 2011; Saxton and Sabatini, 2017; Yu et al., 2011) . This establishes negative feedback that balances mTORC1 and mTORC2 activities ( Figure 1A ). Many RNA viruses employ cap-independent modes of translation initiation and suppress mTORC1 to inhibit host protein synthesis (Jan et al., 2016) . By contrast, many DNA viruses impair host translation by impairing mRNA biogenesis, export, and/or stability and often stimulate mTORC1 to foster cap-dependent translation of their own mRNAs (Jan et al., 2016) . A common strategy to do so is receptor-mediated activation of PI3K. Additionally, for example, myxomavirus M-T5 protein binds and activates Akt, cytomegalovirus UL38 binds and inactivates TSC, and the herpes simplex virus type 1 (HSV-1) kinase Us3 acts as an Akt mimic (Chuluunbaatar et al., 2010; Jan et al., 2016; Werden and McFadden, 2008) . However, there are no reports of viruses targeting mTORC1 or mTORC2 directly.
Beyond exploiting host metabolic regulators, viruses must also contend with an armory of immune sensors aimed at detecting their presence (Chen et al., 2016) . While all viruses must evade RNA sensors, DNA viruses face the added obstacle of complex DNA sensing pathways. Most, if not all DNA sensors activate stimulator of interferon (IFN) genes (STING) that recruits tank-binding kinase 1 (TBK1) to phosphorylate IFN response factor 3 (IRF3). IRF3 then translocates to the nucleus to induce IFNstimulated gene (ISG) expression (Ishikawa and Barber, 2008; Sun et al., 2009; Zhong et al., 2008) . While nuclear DNA sensing and viral evasion strategies are well characterized, our understanding of cytosolic DNA sensing is still in its infancy (Chen et al., 2016) . Among the primary cytosolic sensors identified, AIM2 mainly initiates inflammatory responses (Hornung et al., 2009) , while Toll-like receptor 9 (TLR9) and cyclic-di-GMP-AMP (cGAMP) synthetase (cGAS) function in antiviral immunity (Chen et al., 2016) . TLR9 is expressed in specialized immune cells. By contrast, cGAS is the primary cytoplasmic DNA sensor expressed in many cell types. Upon binding DNA, cGAS produces cGAMP that directly activates STING (Ablasser et al., 2013; Diner et al., 2013; Gao et al., 2013b; Sun et al., 2013; Zhang et al., 2013) . However, while cGAS can detect DNA virus genomes and retroviral DNA products (Gao et al., 2013a; Lahaye et al., 2013) , its role in sensing infection is complicated by the fact that it functionally cooperates with IFI16, the primary sensor for many nuclear-replicating viruses (Almine et al., 2017; Chen et al., 2016; Orzalli et al., 2015) . Indeed, in most instances, viral DNA in the cytoplasm is both limited in quantity and shielded within viral capsids.
A notable exception is infection by poxviruses, a family of extraordinarily self-sufficient DNA viruses that replicate entirely in the cytoplasm within structures called viral factories (VFs) (Moss, 2015; Smith et al., 2018) . Poxviruses include Variola virus (VarV), the causative agent of smallpox, and Vaccinia virus (VacV), the smallpox vaccine and laboratory prototype for poxvirus studies. Poxvirus infection initiates in dermal fibroblasts followed by skin-resident macrophages or in alveolar macrophages, in the case of aerosol transmission. Macrophages then carry the virus to the blood stream, where it spreads to distal sites, replicating once again in dermal fibroblasts to cause characteristic pustules. Recent studies have established that although TLR9 plays a minor role in sensing poxvirus infection in immune cells, cGAS is its primary sensor (Dai et al., 2014; Georgana et al., 2018) . However, the nature of the cGAS response and the viral antagonist that allows poxviruses to replicate remain mysterious. Here, we show that poxviruses evade cytosolic sensing through a conserved structural protein that disrupts an mTORC1-mTORC2 regulatory circuit.
RESULTS mTOR Signaling Becomes Akt Independent during Poxvirus Infection
VacV biphasically activates PI3K-Akt-mTOR signaling, first during early entry and again at later stages (Soares et al., 2009; Zaborowska and Walsh, 2009) . As prior studies used PI3K, Akt, or mTOR inhibitor pre-treatments, effects on early replication confound our understanding of mTOR function at later stages. To address this, we tested the effects of inhibitors when added after infection was already established in growtharrested primary normal human dermal fibroblasts (NHDFs), a natural target cell type for infection in vivo. In NHDFs, infection enters late stages $16-20 hr post infection (hpi), characterized by the onset of host translation shut-off and increasing synthesis of late poxvirus proteins ( Figure S1A ). To compare translational dependencies on mTOR, uninfected or VacV-infected NHDFs were pulsed between 20 and 22 hpi with either of two mTOR catalytic site inhibitors, PP242 or Torin1. Western blot (WB) analysis of two of mTORC1's best-characterized substrates, p70S6K and 4E-BP1 (Saxton and Sabatini, 2017) , confirmed the efficacy of inhibitors in both uninfected and infected cells ( Figure S1B ).
35 S-Met/Cys labeling showed that although poxviruses modify ribosomes and can utilize capdependent or cap-independent initiation (Dhungel et al., 2017; , maximal rates of host or late viral protein synthesis were similarly dependent on mTOR ( Figure S1B ). This was also observed in HEK293A or BSC40 cells ( Figure S1B ). However, slower-migrating phosphorylated forms of p70S6K and 4E-BP1 persisted in infected cells when cultures were pulsed in a similar manner using the Akt inhibitor, AKTVIII, despite effective inhibition of Akt ( Figure S1C ). This revealed that once infection was established, Akt was no longer able to signal to mTORC1.
A Poxvirus Protein Sequesters Raptor and Rictor to Activate mTOR
Given this observation, we tested whether VacV affected the composition of mTORCs in NHDFs. Two independent antimTOR antibodies co-immunoprecipitated (coIPed) mLST8, a C-terminal-binding mTOR activator (Kim et al., 2003) , but not unrelated proteins such as ERK1/2 ( Figure 1B ). However, VacV reduced the recovery of Raptor. This was not unique to NHDFs, as VacV also reduced the binding of both Raptor and Rictor to mTOR in HEK293A cells ( Figure 1C ). The relative enrichment of Rictor in coIP complexes over input lysates was greater than that for Raptor, and this was also observed in NHDFs below. This is in line with reports that Rictor binds mTOR more tightly than Raptor in several cell lines (Sarbassov et al., 2004) .
To determine whether VacV encoded a protein(s) to control mTOR, we performed coIP-based screens of components of the PI3K-Akt-mTOR signaling pathway in metabolically labeled NHDFs. This approach exploits the fact that VacV induces host translation shut-off, and although target proteins are recovered in coIPs (Figures 1B and 1C and below) , most 35 S-labeled proteins in infected cells are viral. Screens identified an $11-kDa protein in Raptor or Rictor coIPs but not Akt or mTOR coIPs (Figures 1D and S2A) . Low levels of synthesis and association of this protein with Raptor were detectable at earlier times ( Figure S2B ), showing that it was produced coincident with the switch to late stages of infection. This Raptor-associated protein was also evident on silver-stained gels ( Figure 1E ), and mass spectrometry identified it as F17 (formerly called F18; GenBank: AAO89335.1).
F17 is an abundant and conserved poxvirus structural protein required for the formation of infectious virions, with no known non-structural function (Wickramasekera and Traktman, 2010; Zhang and Moss, 1991) . To assess whether F17 was required for VacV to displace Raptor or Rictor, we infected NHDFs with wild-type (WT) VacV or the mutant vRR10K (Zhang and Moss, 1991) . vRR10K expresses F17 under the control of isopropylb-D-thiogalactose (IPTG) to generate virus stocks. Virion-resident F17 is rapidly degraded upon cell entry (Schmidt et al., 2013) , and the mutant then effectively operates as a null virus (DF17) in the absence of IPTG. CoIP of mTOR complexes from infected NHDFs revealed that unlike WT virus, DF17 was unable to reduce Raptor or Rictor binding to mTOR ( Figure 1F ). Infections also showed that unlike WT virus, DF17 failed to hyperphosphorylate p70S6K ( Figure 1G ). Notably, DF17 elicited a modest increase in p70S6K phosphorylation over uninfected cells that, unlike WT infection, was sensitive to Akt inhibition. Thus, F17 hyper-activated mTOR and rendered it unresponsive to Akt, while moderate Akt-dependent signaling occurred in the absence of F17.
Immunofluorescence (IF) imaging further revealed that in uninfected cells, both mTOR and Raptor were present in the nucleus and cytoplasm, similar to other cell types (Betz and Hall, 2013) . While their nuclear fractions appeared unaffected, in 94.5% of WT-infected cells, a population of mTOR, but not Raptor or Rictor, concentrated at perinuclear regions (Figures S2C and S2D) . By contrast, mTOR did not relocalize in DF17-infected cells. Cumulatively, this suggested that F17 caused mTOR, lacking its regulatory subunits, to redistribute to perinuclear sites during infection.
F17 Binds an Evolutionarily Conserved Region in Raptor
Testing F17 functionality outside the context of infection, FLAG-tagged F17 specifically bound Raptor and Rictor, but not Akt, when expressed in HEK293A cells (Figure 2A ). F17 was recovered more readily in Raptor than in Rictor complexes, reflecting observations in NHDF-based screens ( Figure 1D ). Conversely, recovery of mTOR and mLST8 was higher in Rictor than in Raptor complexes, again suggesting Rictor binds mTOR more tightly than Raptor. These inverse relationships suggested that F17 competed with mTOR for binding to Raptor and Rictor. mTOR's HEAT repeats (HRs) make several contacts with either Raptor or Rictor (Aylett et al., 2016; Kim et al., 2002; Sarbassov et al., 2004; Stuttfeld et al., 2018) . This involves both residues within a unique Raptor N-terminal conserved (RNC) domain and tryptophan-aspartic acid (WD) repeat domains in Raptor's C terminus ( Figure 2B ). Although both domains are required for mTOR to bind Raptor, mTOR is unable to interact with either domain individually (Kim et al., 2002) (Figure 2C ). By contrast, F17 bound to either full-length or the N-terminal half of Raptor harboring the RNC and short HR domain. Although it expressed poorly, a minimal RNC also bound F17, while the C-terminal WD repeats did not. Furthermore, F17 binding to full-length Raptor was found to depend upon four distinct, highly conserved amino acid stretches in the RNC that are required for mTOR binding (Kim et al., 2002) (Figure 2D ). As far as we are aware, this is the only protein known to bind the RNC alone and supports the notion that F17 competes with mTOR for Raptor binding. In line with this, co-expression of the Raptor-binding HR region of mTOR with F17 in HEK293A cells reduced F17 binding to endogenous Raptor ( Figure 2E ).
Under conditions that affected F17 binding to Raptor, F17 abundance was also partially reduced ( Figures 2C-2E ). This suggested that binding to Raptor helps stabilize F17. F17 is phosphorylated at S53 and S62, but this is not required for virion formation, and the function, if any, of its phosphorylation remains mysterious (Wickramasekera and Traktman, 2010) . These sites lie within an internal disordered region ( Figures 2F,  S3A , and S3B), and such regions often function in protein binding. Expression of F17 or F17 mutants with serine-to-alanine (S-A) or serine-to-glutamic-acid (S-E) substitutions showed that S-A mutations at either site individually had minimal effects on F17 association with Raptor, while mutation of both sites potently impaired this interaction (Figures 2G and S3C) . By contrast, an F17 S-E phosphomimetic retained Raptor binding activity. Although infection stimulates host kinases that phos- phorylate F17 (Wickramasekera and Traktman, 2010) , binding of exogenously expressed F17 to Raptor remained dependent on both S53 and S62 in DF17-infected cells ( Figure 2H ). The S53/62A mutant that failed to bind Raptor was also partially reduced in abundance in both uninfected and infected cells, further suggesting that its interaction with targets such as Raptor enhances F17 stability. Finally, expression of F17 or the mTOR HR region showed that Raptor/Rictor-binding proteins can enhance p70S6K and 4E-BP1 phosphorylation in NHDFs ( Figure 2I ). As such, F17 binds the Raptor RNC and regulates mTOR activity.
F17 Is Required to Counter Antiviral Responses in Natural Target Cells
We next assessed how the absence of F17 impacted infection. WB analysis of the early-intermediate protein I3 revealed no significant defects in early viral protein expression, while p70S6K mobility shifts showed modest stimulation of mTOR activity by both WT and DF17 viruses at early times ( Figure S4A ). However, although the accumulation of I3 and initial low levels of late (D8 and A14) viral proteins were comparable up to 16 hpi, beyond this point, virus lacking F17 failed to continue producing late proteins ( Figure 3A ). DF17 also failed to induce host translational shutoff, and viral proteins were poorly synthesized. This coincided with the failure of DF17 to hyper-phosphorylate p70S6K at this mid-late transition, again eliciting only intermediate mTOR activation. These observations contrasted with earlier studies showing that the exact same DF17 mutant synthesized all other viral proteins to normal levels and had no translational defects (Zhang and Moss, 1991) . However, these studies were performed in BSC40, a transformed African green monkey kidney cell line. Confirming this, viral intermediate and late proteins accumulated to comparable levels in WT-or DF17-infected BSC40 cells or human HEK293A cells, contrasting with NHDFs ( Figure 3B ). mTOR substrates were hyper-activated even in uninfected BSC40, preventing assessment of the effects of infection in these cells. However, in HEK293A, WT VacV induced phosphorylation of mTORC1 substrates, p70S6K and 4E-BP1, as well as mTORC2 substrate Akt S473 . Neither p70S6K nor 4E-BP1 were hyper-activated as efficiently in HEK293A compared with NHDFs, and HEK293A expressed significantly higher levels of Raptor and Rictor. This supported the notion that the abundance of F17 relative to its host targets dictates the degree of mTOR hyper-activation and therefore operated more efficiently in normal cells. In addition, intermediate mTOR signaling was observed in DF17-infected HEK293A cells ( Figure 3B ). Combined, this established that F17 was required to sequester Raptor and Rictor and to hyper-activate mTOR regardless of whether infection progressed normally to express all other viral proteins in HEK293A cells or stalled in NHDFs. The phenotype of DF17 infection resembled that of WT infection in IFN-primed NHDFs ( Figure S4B ) but was distinct from that of the protein kinase R (PKR) response; PKR detects doublestranded RNA (dsRNA) produced by many viruses and phosphorylates eIF2a, resulting in the shutdown of both host and viral protein synthesis (Jan et al., 2016) . Although PKR was differentially expressed between cell types ( Figure 3B ), eIF2a was not phosphorylated during DF17 infection, despite the fact that NHDFs mount a characteristic PKR-based response to poxviruses lacking any of their PKR antagonists, C7, K1, or E3 (Meng et al., 2008; Smith et al., 2018; Willis et al., 2009) (Figure S4C ). Like most, if not all, VacV immune modulators, these proteins are expressed early in infection, suggesting that F17 was required to counter a distinct response at later stages.
F17 Is Required to Counter cGAS-STING Activation
Analysis of DNA sensing pathways showed that BSC40 cells expressed IFI16, STING, TBK1, and low levels of AIM2, but not cGAS ( Figure 3B ). HEK293A cells expressed AIM2, STING, and TBK1, but not cGAS or IFI16, in line with prior reports . By contrast, although AIM2 levels were low, NHDFs expressed all sensors tested, including cGAS. In all cells, WT VacV reduced the abundance of basally expressed ISG56. However, in BSC40 or HEK239A cells, neither WT nor DF17 infection resulted in the induction of the ISGs, MxA or MxB, nor did they activate STING or TBK1. This suggested that neither IFI16 nor AIM2 were sufficient to mount an antiviral response to poxvirus. Indeed, although studies report the presence of IFI16 at VFs (Almine et al., 2017) , this is not universally observed in all cell types (Kerur et al., 2011) and was only detectable in 7.3% of VFs in NHDFs (Figures S5A and S5B) . Despite this, NHDFs mounted an antiviral response to DF17, phosphorylating STING and TBK1, resulting in nuclear translocation of IRF3, and to a lesser extent, NFkB, and inducing ISG accumulation (Figures 3B, . Moreover, mRNA levels for IFNb, ISG56, MxA, MxB, and to a lesser extent, cGAS, were elevated in NHDFs infected with DF17 ( Figure 3D ). WT VacV reduced ISG56 mRNA levels, which likely explains why its protein levels are reduced in all three cell lines regardless of their response to DF17 ( Figure 3B ).
These findings are in line with recent evidence that cGAS is the primary poxvirus sensor (Dai et al., 2014; Georgana et al., 2018) . Notably, WT VacV reduced the protein abundance of cGAS while it was slightly elevated at both the protein and mRNA levels in DF17-infected NHDFs, in line with cGAS itself being an ISG (Figures 3B and 3D) . However, WT VacV did not reduce cGAS mRNA levels. The reduction in cGAS protein by VacV was blocked by the proteasome inhibitor MG132, impairing viral protein production and ISG56 downregulation ( Figure 3E ). Thus, VacV drives proteasomal degradation of cGAS, and this is explored further below. Notably, there were no significant differences in the inhibition of IFNa, IFNb, or IFNg release by NHDFs infected with WT VacV or DF17 ( Figure 3F ). This, together with a lack of PKRbased responses to DF17, was in line with normal progression through early stages and expression of early immunomodulatory proteins that inhibit many antiviral pathways and block IFN secretion and activity (Smith et al., 2018) , indicating that F17 blocked cGAS-STING activation later in infection. Finally, DF17 also failed to hyperactivate mTOR and stimulated the STING pathway in another biologically relevant cell type, monocytic THP-1 cells that were differentiated into macrophages (Figures 3G and S6A) . Moreover, despite the technical challenges involved, core aspects of this response were also observed in primary CD14+ peripheral blood mononuclear cells (Figures S6B and S6C) . Although detectable, the degradation of cGAS was less robust in WT VacV-infected THP-1 cells ( Figure 3G ), which express far higher levels of cGAS than NHDFs (Figure S6D ). This suggested that VacV only degrades a subpopulation of cGAS, explored further below.
Compared with WT VacV, DF17 formed extremely small DNAfilled VFs in NHDFs, suggesting that poxvirus DNA was sensed and infection was stalled in the absence of F17 ( Figure 4A ). In line with this, treating cells with the DNA polymerase inhibitor cytosine arabinoside (AraC) to block production of viral DNA suppressed the host response to DF17 ( Figure 4B ). During WT VacV infection, AraC blocked progression to late stages, preventing F17 expression and impairing both p70S6K hyperphosphorylation and ISG56 downregulation ( Figure 4B ). This demonstrated that both host responses and viral countermeasures revolved around VF formation and the transition to late (legend continued on next page) stages of infection. Similar effects were seen with Rifampicin ( Figure 4B ). This was unexpected, as Rifampicin is not thought to inhibit the viral DNA polymerase but blocks virion maturation (Moss, 2015) . However, Rifampicin also caused p70S6K hypophosphorylation in both uninfected and VacV-infected NHDFs. As such, this additional property of Rifampicin provided initial hints that mTOR played a role in both host responses and viral evasion processes. cGAS activates STING, which then translocates from the endoplasmic reticulum (ER) to the ER-Golgi intermediate complex (ERGIC) and Golgi (Chen et al., 2016) . While only basal levels of phosphorylated STING were detected at the Golgi in uninfected or WT-infected cells, in DF17-infected cells, ER vesicles concentrated around the Golgi, where large phosphorylated STING puncta were observed ( Figures 4C and 4D ). Moreover, a fraction of cGAS overlapped with ER vesicles in uninfected NHDFs, and an increase in both ER and cGAS staining intensity around the Golgi was detected in $95% of DF17-infected cells ( Figures 5A and 5B ). In WT-infected cells, this translocation did not occur, and the Golgi periphery was distinctly devoid of cGAS. This cGAS-ER localization overlap and translocation in response to DF17 infection was also observed in $95.8% of THP-1 cells ( Figures 5C and 5D ). In WT-infected THP-1 cells, the Golgi periphery was not as devoid of cGAS as in NHDFs, and moderate cGAS localization near the Golgi could be observed in $40% of cells ( Figure 5D ). The size of VFs was smaller ( Figure 5D ), and VacV replication kinetics were slower in THP-1 than in NHDFs (Figure S6E versus 3A) . This suggested that high levels of cGAS expression in immune cells swamped the viral mTOR-mediated destabilization counter-strategy. In line with this, when endogenous cGAS in NHDFs was complemented with GFP-cGAS (Raab et al., 2016; Yang et al., 2017) , direct imaging of GFP signal revealed accumulation of GFPcGAS puncta at the Golgi periphery in response to DF17 infection ( Figures 5E and 5F ). Moreover, in WT-infected cells, regions devoid of GFP-cGAS around the Golgi were less evident, and VFs were notably smaller, similar to THP-1 cells. Poxviruses replicate in dermal fibroblasts to cause pustules but elicit potent immune responses, and differential cGAS expression between natural target cells may be a fundamental aspect of this in vivo biology.
In HEK293A cells, GFP-cGAS transfection induced ISG56 expression likely by detecting its own encoding plasmid DNA, yet only very modest effects on viral protein accumulation were observed ( Figure 5G ). However, similar to recent reports in actively dividing cells (Yang et al., 2017) , cGAS was not only expressed at heterogenous levels, but among 63.4% cells expressing high levels, GFP-cGAS was localized to the nucleus in most cases ( Figure 5H ). This would not prevent detection of many DNA stimuli, since most translocate to the nucleus, but likely limits detection of poxviruses. Moreover, in cells where cGAS was cytoplasmic, it did not detectably translocate in response to DF17 ( Figure 5H ). These may be transient cytoplasmic pools of cGAS limiting responses to poxvirus infection. Alternatively, in addition to lacking cGAS and IFI16, HEK293A may also lack other, yet unidentified cGAS regulators that operate in natural target cells. Indeed, HEK293T cells also lack STING (Orzalli et al., 2015; Sun et al., 2013) .
mTOR Regulates Antiviral Responses and Viral Countermeasures
Having noted its perinuclear accumulation earlier, staining revealed that dysregulated mTOR localized to the Golgi in WT-infected cells where again, peripheral regions devoid of cGAS were evident in $94.1% of cells ( Figure 6A ). While the brighter cGAS exposures shown mask differences in abundance, they illustrate the broader localization of cGAS through the cell that includes small fractions at VFs ( Figure S7 ). Concentration of cGAS at VFs would not be expected if it subsequently translocated with ER vesicles to the Golgi periphery. Indeed, cGAS accumulated around the Golgi in 95.4% of DF17-infected cells imaged. This suggested that localization of dysregulated mTOR to the Golgi enabled VacV to counter this response. Notably, Akt can destabilize cGAS (Seo et al., 2015) , but connections to mTOR have not been made. Treatment of cells with the Akt inhibitor AKTVIII blocked VacV-induced cGAS downregulation and reduced the accumulation of viral proteins ( Figure 6B ). This was also observed with the mTOR inhibitors Torin1 and PP242, but in these cases, cGAS levels were notably lower than in DMSO or AKTVIII-treated samples. This was in line with the notion that while Akt regulates cGAS stability, mTORC1 activity enhances the synthesis of ISGs that include cGAS. As such, control of translation by mTORC1 and Akt by mTORC2 positions mTOR as a master regulator of cGAS synthesis and stability. Although poxvirus infection renders Akt unable to signal to mTORC1, the virus continues to utilize mTOR-mediated control of Akt to promote cGAS degradation and continues to depend on Akt for infection.
If competitively sequestering Raptor enabled VacV to replicate more effectively, providing Raptor in trans should tilt the balance in favor of the host response. To test this, we generated two independent pools of NHDFs expressing FLAG-tagged Raptor and infected them with different doses of VacV. With higher input doses and greater virus spread in control NHDFs, ISG56 levels were correspondingly more reduced ( Figure 6C ). In both Raptor-overexpressing pools, ISG56 levels were elevated, likely through mTORC1-mediated translational upregulation, and VacV spread was correspondingly suppressed. While these spreading assays tease out subtle benefits to the host, sufficient Raptor overexpression to robustly outcompete the highly abundant F17 protein at high MOI was difficult to achieve. This approach also did not allow us to test mTOR functionality in host responses to the replication-defective DF17 virus. As such, we tested the broader role of mTOR using Torin1 and (E and F) NHDFs expressing GFP-cGAS infected as in (A) and stained with TGN46 (Golgi) and Hoechst. GFP is imaged directly. White boxes highlight cGAS localization relative to the Golgi. Green box highlights smaller VFs in GFP-cGAS expressing NHDFs. (legend continued on next page) PP242. mTOR inhibition impaired WT VacV's ability to suppress ISG56 expression and reduced viral protein production (Figure 6D) . Conversely, mTOR inhibition dampened STING and TBK1 phosphorylation and suppressed host ISG responses to DF17. Moreover, while IRF3 translocated to the nucleus in response to DF17 in DMSO-treated controls, this was greatly reduced when mTOR was inhibited ( Figures 6E and 6F) . The low percentage of IRF3 translocation that persisted likely represents incomplete mTOR inhibitor activity in a small fraction of cells, in line with the detection of a low level of continued ISG induction in samples analyzed by WB. Combined, this established mTOR as a central regulator of both host responses and poxvirus countermeasures.
HSV-1 is a large nuclear-replicating DNA virus that activates PI3K and also encodes an Akt mimic, Us3, to indirectly activate mTORC1 (Chuluunbaatar et al., 2010) . We infected NHDFs with two independent HSV-1 mutant sets: a Us3 deletion alongside its parental virus and a Us3 deletion mutant repaired with WT or kinase-dead Us3 (Chuluunbaatar et al., 2010) . Both Us3 mutants were defective in mTORC1 activation, yet all four viruses induced ISG expression ( Figure 6G ). This is perhaps not unexpected, as some viruses exploit ISGs or encode proteins that inhibit ISG activity that allows them to replicate. Most notably, HSV-1 degraded IFI16, but not cGAS or STING, in line with prior reports (Orzalli et al., 2012; Seo et al., 2015) , and this was irrespective of Us3 activity. As such, poxviruses counter cytosolic sensing through a unique strategy of directly targeting and dysregulating mTORCs (Figure 7 ).
DISCUSSION
Because of their roles in promoting substrate phosphorylation, Raptor and Rictor are often viewed as stimulatory factors for mTOR. However, both proteins occlude the mTOR active site and dictate mTOR's substrate specificity (Aylett et al., 2016; Hsu et al., 2011; Kang et al., 2013; Schalm et al., 2003; Yip et al., 2010) . In its original discovery, Raptor binding was found to repress mTOR activity under nutrient-poor conditions, and its removal in vitro activated mTOR (Kim et al., 2002) . As such, in specific contexts, mTOR becomes unresponsive to cues by becoming constitutively activated, not repressed upon loss of its regulators. Here, we show that poxviruses remove Raptor and Rictor to render mTOR constitutively active and beyond host control. Dysregulated mTOR translocated to the Golgi. While its amino acid sensing activities at lysosomes are widely studied (Saxton and Sabatini, 2017 ), mTOR's functions at other cellular compartments are less defined (Betz and Hall, 2013) . Our findings reveal that dysregulated mTOR at the Golgi enables poxviruses to counter host antiviral responses while retaining the metabolic benefits of activated mTOR (Figure 7 ). STING and mTOR have recently been shown to cooperate during responses to cyclic-di-AMP produced by Gram-positive bacteria (Moretti et al., 2017) . Activated STING initiates ER stress that is then resolved by repressing mTORC1, and this resolution is necessary for maximal STING activation and an effective IFN response. Moreover, STING and mTORC1 activities appear coordinately controlled during these responses. Our data suggest that a similar process occurs during poxvirus infection that becomes evident in the absence of its antagonist, F17; STING is activated and ER vesicles relocalize, yet appropriate host control of mTOR is required for maximal STING activation, IRF3 translocation to the nucleus, and ISG induction. This involves careful balancing of mTORC1-mTORC2 activities, as excessive dampening of mTORC1 to resolve ER stress would not only reduce ISG translation but would also increase mTORC2-mediated cGAS degradation (Figure 7 ). mTORC1-mTORC2 crosstalk is likely particularly important in the case of responses to poxvirus that involve cGAS, rather than bacterially produced cyclic-di-AMP. While cGAS does not need to translocate in order to transmit its activating cGAMP signal to STING (Ablasser et al., 2013; Ishikawa and Barber, 2008; Takahama et al., 2017) , our data suggest mTOR dysregulation allows poxviruses to degrade a subpopulation of cGAS, likely that which accumulates with ER vesicles around the Golgi. Fractions of cGAS and STING co-sediment with small vesicles , and cGAS translocates in response to some bacterial infections (Collins et al., 2015; Zhang et al., 2014) . Moreover, for yet unknown reasons, inhibitory phosphorylation or glutamylation of only a small fraction of cGAS can inhibit its activity in cells (Seo et al., 2015; Xia et al., 2016) . As such, cGAS may form functionally specialized subpopulations that respond to different stimuli, and cGAS at the ER may play a specific, yet unknown role in responding to poxviruses. Indeed, much of our understanding of cGAS derives from transformed cell lines yet additional layers of regulation undoubtedly await discovery in primary cells in natural contexts.
Poxviruses produce $100 immunomodulatory proteins (Smith et al., 2018) . These are encoded by open reading frames (ORFs) that lie in genetically variable arms that flank the conserved core of essential structural and replicative genes. Immunomodulatory genes undergo high rates of recombination and exhibit remarkable plasticity that enables host adaptation (Elde et al., 2012; Smith et al., 2018) . As such, they vary considerably between different poxviruses and are important determinants of host range and in vivo immune responses yet are often dispensable in culture. Most, if not all, are expressed early in infection and serve to inhibit antiviral proteins such as PKR or barrier to autointegration factor (BAF), as well as to block the production, secretion, and even extracellular activity of IFNs (Jan et al., 2016; Smith et al., 2018; Wiebe and Traktman, 2007 ). Yet how (E) Mock or DF17-infected NHDFs treated with DMSO, Torin1 (100 nM), or PP242 (2.5 mM) at 8 hpi and fixed for staining at 24 hpi. Boxes highlight nuclei. poxviruses evade DNA sensing has remained enigmatic. IFI16 and DNA-PK, which are predominantly nuclear but can translocate to the cytoplasm, have been implicated in sensing poxvirus infection (Almine et al., 2017; Peters et al., 2013) . However, the only known viral antagonist that targets DNA-PK, C16, is dispensable for poxviruses to block STING activation (Georgana et al., 2018) . Moreover, recent studies suggest that cGAS is the primary poxvirus sensor and that STING evasion is conserved across all virulent poxviruses (Dai et al., 2014; Georgana et al., 2018) . Cumulatively, these findings suggest that poxviruses broadly counter DNA sensing pathways that converge on STING. A notable feature of avirulent poxviruses that fail to prevent STING activation is that they do not express late viral pro- (1) mTORC2 regulates cGAS stability, (2) reducing mTORC1 activity resolves STING-induced ER stress into an IFN response, and (3) mTORC1 enhances translation of ISGs after they are induced. As lowering mTORC1 activity to resolve ER stress results in lower ISG translation and stimulates mTORC2 that degrades cGAS, mTORC1-mTORC2 crosstalk carefully balances the host response pathway. HSV-1 replicates in the nucleus and does not need to disrupt mTORC1-mTORC2 crosstalk to counter cGAS but instead encodes antagonists of nuclear sensors (e.g., IFI16, DNA-PK), as well as IFNs and PKR. (B) Poxvirus F17 blocks STING-mediated antiviral responses. By disrupting the mTORC1-mTORC2 regulatory circuit, F17 drives cGAS degradation while also blocking STING-mediated ER-stress resolution and IRF3 translocation to the nucleus. This broadly counters other DNA sensors that also signal through STING, complementing the activities of sensor-specific antagonists. While disrupting sensing, this dysregulation strategy retains the benefits of mTOR-mediated stimulation of viral protein synthesis. teins in restrictive cell types. Here, we reveal that cGAS-STING responses are counteracted on multiple levels by the late structural protein, F17. In addition to destabilizing cGAS, mTOR dysregulation also impairs downstream activities of STING required for IRF3 translocation and ISG induction. As such, F17 provides a means to broadly impair DNA sensing pathways, complementing the activities of sensor-specific factors such as C16 (Figure 7 ). It would make sense for poxviruses not to encode a central antagonist in their highly variable immunomodulatory regions. Unlike many of their hostrange determinants, F17 is evolutionarily conserved across all poxviruses (Wickramasekera and Traktman, 2010). Moreover, there are no recognizable homologs of F17, suggesting that this may be a unique strategy employed by poxviruses to counter cytosolic sensing. The cGAS-STING pathway evolved 600 million years ago and functionally diversified in vertebrates to sense DNA (Margolis et al., 2017) , while Raptor and Rictor coevolved with mTOR and are conserved across all eukaryotes (Tatebe and Shiozaki, 2017) . This suggests that F17 may have developed the ability to bind and sequester mTOR regulatory proteins early in poxvirus evolution and forms a core poxvirus strategy in the evolutionary arms race to counter cytosolic sensing.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Derek Walsh (derek.walsh@northwestern.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Culture Primary Cells Primary Normal Human Dermal Fibroblasts (NHDFs) isolated from human male neonatal foreskin were obtained from Lonza (CC-2509). NHDFs are fully characterized and certified free of mycoplasma, bacteria, yeast, fungi, HIV-1, hepatitis B and hepatitis C by the supplier. NHDFs were cultured in Dulbecco's Modified Eagle's Medium (DMEM; Fisher Scientific) containing 5% Fetal Bovine Serum (FBS), 2 mM L-Glutamine and penicillin-streptomycin and maintained at 37 C, 5% CO 2 . For infection experiments, NHDFs were growth-arrested by washing confluent cultures three times in PBS and maintaining cells in DMEM with 0.2% Fetal Bovine Serum (FBS), 2 mM L-Glutamine and penicillin-streptomycin for 3 days (Walsh and Mohr, 2004) . Peripheral blood mononuclear cells (PBMCs [male]) were isolated from LifeSource Buffy Coat blood using Ficoll-Plaque (GE) by the Northwestern University Third Coast Centers for AIDS Research (CFAR) Core Facility. For infections, monocytes were isolated from PBMCs using CD14 Microbeads (Miltenyi Biotec) and plated at 2.5 3 10^5 cells per well of a 12-well plate. Ethical approval for the study was obtained from the Institutional Review Board of Northwestern University and all donors provided their written, informed consent.
Cell Lines HEK293A (a more adherent sub-clone of HEK293 cells [female]) were obtained from Jeremy Luban, UMass School of Medicine and described previously (Delaney et al., 2017) . BSC40 and VERO cells (female) were obtained from Dr. Ian Mohr, NYU and cultured as described previously (Walsh and Mohr, 2004) . HEK293 Phoenix-Ampho and HEK293T cells (female) used to generate retroviruses were from the ATCC. These cell lines were cultured in Dulbecco's Modified Eagle's Medium (DMEM; Fisher Scientific) containing 5% Fetal Bovine Serum (FBS), 2 mM L-Glutamine and penicillin-streptomycin and maintained at 37 C, 5% CO 2 . Human monocytic THP-1 cells (male) were obtained from Dr. Thomas Hope, Northwestern University, and cultured in RPMI 1640 (GIBCO) containing 10% Nu-serum growth medium supplement (Corning, 355000), penicillin-streptomycin solution (HyClone) and glutamine (Corning). For infection experiments, 5x10^5 THP-1 monocytes are plated on each well of 12-well plate and differentiated into macrophages by incubating with 30ng/ml phorbol 12-myristate 13-acetate (PMA, Sigma, P8139) for 48 h, followed by maintenance for a further 48h in the absence of PMA. All cell lines used were confirmed free of mycoplasma by DNA staining. Beyond those of the original suppliers, no independent authentication procedures were performed on our part for cell lines used.
Viruses
All Vaccinia Viruses used were in the background of the strain Western Reserve (WR). Wild-type (WT) VacV was obtained from Dr. Stewart Shuman, Memorial Sloan Kettering. DF17 virus (vRR10K) was obtained from Dr. Bernard Moss, NIH and grown in BSC40s in the presence of 5mM IPTG, which was washed from cultures prior to virus stock preparation (Zhang and Moss, 1991) . DK1, DC7 and DE3 viruses were provided by Dr. Yan Xiang, University of Texas Health Science Center (Meng et al., 2008; Willis et al., 2009) . VacV stocks were grown and titrated on BSC40 cells. Briefly, cultures were infected at MOI 0.01 and once 90%-100% CPE was observed, virus was harvested by three rounds of freeze-thaw. Cell debris was removed by centrifugation and virus titer was determined by serial dilution and plaque assays on BSC40 cells (Walsh et al., 2008) . HSV-1 WT and Us3 mutants were obtained from Dr. Ian Mohr, NYU School of Medicine and Dr. Richard Roller, University of Iowa (Chuluunbaatar et al., 2010; Ryckman and Roller, 2004) . HSV-1 stocks were grown and titrated using Vero cells using the same approaches as those described for VacV in BSC40 cells, above. In experimental set-ups, VacV or HSV-1 infections were performed at multiplicity of infection (MOI) 5-10 for the indicated times unless otherwise indicated.
METHOD DETAILS
Expression vectors F17 was cloned into expression vectors using primer sequences detailed in Table S1 . Briefly, Flag-F17 was generated by PCR amplification from genomic VacV DNA using forward primers containing an AgeI restriction site and N-terminal FLAG tag and reverse primer with BamHI site. Untagged wild-type and site mutants of F17 were amplified using primers with Age1 and BamH1 sites from plasmids provided by Dr. Paula Traktman (Wickramasekera and Traktman, 2010) . PCR products were resolved in 1% agarose in TAE (Tris base, acetic acid and EDTA buffer) for 1hr at 80V and purified using QIAGEN gel extraction kits. F17 PCR products were digested with Age1-BamHI. The plasmid pQCXIP was Age1-BamHI digested and treated with SAP (Shrimp alkaline phosphatase) for 30 mins at 37 C to prevent plasmid backbone re-ligation without an insert. Vector and target DNA were mixed and ligated using the T4 DNA ligase (NEB) for 1 hr at 16 C. Ligation mixture was used for transformation of DH5a competent bacterial cells. For transformation, ligation reactions were mixed with competent bacterial cells on ice followed by heat shock treatment by placing tubes in water bath at 42 C for 1 min followed by 2 min on ice. 1mL of LB broth without antibiotic was added to the mixture and incubated at 37 C for 1hr. Transformed bacteria were plated on LB agar plates with ampicillin and incubated overnight at 37 C. The following day colonies were picked and inoculated in 3 mL LB broth with ampicillin overnight at 37 C. Plasmids were isolated using plasmid extraction kits (QIAGEN) and diagnostic digests were performed to identify plasmids containing inserts. pTRIP-CMV-GFP-FLAG-cGAS and myc-mTOR Heat Repeat (aa 1-1482) expression plasmids were obtained from Addgene (#86675 and #21745, respectively (Kim et al., 2003; Raab et al., 2016) (Kim et al., 2002) ). HA-tagged Raptor fragments were generated by PCR amplification using the primers indicated in Table S1 . Flag-Raptor was subcloned from the plasmid, pLJM1 Flag Raptor (Addgene, Cat # 26633 (Sancak et al., 2010) ) using AgeI and EcoR1 digestion and ligated into the retroviral vector pBABE-puro (Addgene, Cat # 1764 (Morgenstern and Land, 1990) ). All plasmids generated were fully sequenced at the Northwestern University Sequencing Core.
Stable and Transient Expression of Proteins
Generation of Flag-Raptor-expressing NHDF pools To generate stable pools of NHDFs expressing Flag or Flag-Raptor, retroviral vectors were produced using pBABE-based expression vectors described above. 293 Phoenix-Ampho cells were grown in a 10cm dish with DMEM 5% FBS antibiotic free media. 10mg of Flag or Flag-Raptor plasmid was transfected using Lipofectamine 3000 transfection reagent. 24hr post transfection media was changed to fresh DMEM 5% FBS antibiotic free media. Supernatants were harvested 48hr post transfection. Supernatants were subjected to centrifugation at 4,000 rpm at 4 C for 4 minutes to remove debris and filtered through a 0.45 mM filter. Aliquots of virus stocks were made and stored at À80 C. Two different Flag-Raptor plasmids and virus preparations were used for separate transductions and selection of distinct NHDF pools, named Flag-Raptor1 (R1) and Flag-Raptor 2 (R2). NHDFs were transduced with Flag or Flag-Raptor retroviral vectors. The viral inoculum was removed after 5 hr and medium was replaced with fresh DMEM containing 5% FBS, 1% penicillin/streptomycin and glutamine. After 24 hr media was again changed to growth medium containing puromycin (0.8 mg/ml) to select stably expressing pools. Transient Expression of Proteins Transient expression of proteins was performed using electroporation or lipid-based transfection. For electroporation, briefly a 10-cm dish of NHDFs at 50%-70% confluency was trypsinized and centrifuged at 200xg for 10 minutes at room temperature. The media was aspirated off the cell pellets and the pellets were then each gently resuspended in 100 mL of supplemented Human Dermal Fibroblast Nucleofector solution. 2.5 mg of plasmid was then added and mixed into the solution before the entire volume was transferred into a cuvette (Amaxa P2 Primary Cell 4D-Nucleofector Kit). The cells were then electroporated using a Lonza 4D-Nucleofector device, set to program DT130 (NHDF-neo). After electroporation, the cells were immediately resuspended in 1 mL of equilibrated medium and seeded for experiments, as detailed in the main text. For lipid-based transfections, 2.5 mg DNA was added per well of a 6-well plate using Lipofectamine 3000 Transfection Reagent, according to the manufacturer's instructions. The following day, cells were harvested for analysis or trypsinized and used to seed for experiments as detailed in the main text and other Methods sections.
Inhibitor/Interferon Treatment Small molecule inhibitors and interferons used in this study were made as 1,000x stocks and sources are detailed in the Key Resource Table. Inhibitors or interferons were diluted in medium and added to cultures at the times and concentrations indicated in figure legends. In all cases where DMSO was used as solvent, the same amount of DMSO was present across all drug-treated or control samples within each experiment.
Metabolic Labeling
For metabolic labeling, cultures were incubated in methionine/cysteine (Met/Cys)-free DMEM (17-204-CL; Corning) containing 40mM HEPES, 2 mM L-Glutamine and penicillin-streptomycin along with 77 mCi 35 S-Met/Cys (NEG072; Amersham) for 30 min prior to cell lysis (Walsh and Mohr, 2004) . Where inhibitors were used, inhibitors were present during labeling. Samples were resolved by SDS-PAGE. Gels were then fixed in a solution of 10% Acetic Acid/25% methanol for 20-30 min. Fixed gels were then dried and exposed to X-ray film.
Western blotting
For western blot analysis, whole cell extracts were prepared by in-well lysis in laemmli buffer (62.5 mM Tris-HCl at pH 6.8, 2% SDS, 10% glycerol, 0.7 M b-mercaptoethanol). Samples were then boiled for 3 min and resolved using reducing polyacrylamide Trisglycine SDS-PAGE, varying gel percentage according to resolution requirements for different proteins. Resolved proteins were transferred to a nitrocellulose membrane (GE Healthcare Life Sciences) at 57 V for 60 min (Mini Trans-Blot system, Bio-Rad), washed in Tris-Buffered Saline (TBS) containing 0.1% Tween (TBS-T) and blocked (5% non-fat milk TBS-T) before incubating with primary antibodies diluted in 3% BSA TBS-T overnight at 4 C. For primary antibodies used see Key Resources Table. Membranes were washed with TBS-T and incubated with the appropriate horseradish peroxidase (HRP)-conjugated secondary antibody (GE Healthcare Life Sciences) diluted 1:3,000 in TBS-T containing 5% non-fat milk for 1 h at room temperature. Membranes were then washed in TBS-T and incubated with Pierce ECL Western Blotting Substrate (Thermo Fisher Scientific) before exposure to X-ray film.
Co-Immunoprecipitation-based screens For IP-based screens in metabolically labeled NHDFs, labeling was performed as described above but for 1h. Cells were then rinsed in PBS and scraped into ice-cold NP40 lysis buffer (50mM HEPES pH 7.4, 150mM NaCl, 0.5mM MgCl 2 , 2mM EDTA, 2mM Na 3 VO 4 , 25mM glycerophosphate, 1.5% NP-40 and completed mini EDTA-free protease inhibitor cocktail [Roche] ) (Walsh and Mohr, 2006) . Samples were mixed by rocking at 4 C for 40-60mins followed with centrifugation at 10,000 g for 10mins. For co-IP screens of metabolically labeled samples using rabbit antibodies, supernatants were pre-cleared by rocking for additional 40 min with 2-5 mL rabbit serum followed by two rounds of IgG removal using Pansorbin (Roche). For mouse antibodies, samples were pre-cleared using Protein G beads. 27 mL of pre-cleared supernatant was retained as input sample and the remainder was transferred to a new Eppendorf tube containing the indicated antibody along with protein A (for rabbit antibody) or G (for Mouse antibody) beads. Samples were mixed by rocking at 4 C for 2 hours followed with centrifugation at 10,000 g for 30 s. Beads were washed in NP40 lysis buffer 3-4 times. Samples were then boiled in Laemmli buffer for 3 min, resolved by SDS-PAGE and exposed to X-ray film as described above. Antibodies used for IP were Raptor, mouse mAb (Millipore); Rictor, mouse mAb (Millipore); Akt, mouse Ab (Millipore); PCBP2, Mouse Ab (Sigma); Raptor, Rabbit Ab (Cell Signaling Technology); mTOR, rabbit Ab (Cell Signaling Technology); HA, rabbit Ab (Sigma). For details of catalog numbers see Key Resource Table. Co-IP Analysis of Protein Complexes For co-IP and western blot analysis of mTOR complexes, samples were rinsed in PBS and lysed in NP-40 lysis buffer as described for co-IPs above. Supernatants were precleared with 25mL of 10% slurry of equilibrated protein A/G beads for 1h rocking at 4 C. After pre-clearing, input samples were taken and remaining supernatants were divided and incubated with either Rabbit control IgG or Rabbit mTOR (Cell signaling technologies) antibody for 2h rocking at 4 C. For IPs with goat mTOR (FRAP; Santa Cruz) antibody, goat IgG control antibody was used. The antibody-lysate mix was then incubated with 40 mL of 10% slurry of equilibrated protein A/G beads for 16h rocking at 4 C. Beads were then washed three times with 700 mL of IP buffer for 5 min. Washed beads were then boiled for 3 min in 50 mL of 2x Laemmli buffer. Similar procedures were used to co-IP Raptor complexes from HEK293A cells for F17 binding assays.
Identification of F17 through co-IP and Mass Spectrometry
Co-IP and Silver Staining For silver staining and mass spectrometry identification of F17, co-IP protocols were as described above except that they were performed on a larger scale in 5 3 10cm dishes and antibodies were cross-linked to beads as follows: 300 mL of 10% slurry protein A beads or 60 mL of 50% protein G were washed twice in PBS buffer followed with centrifugation at 10,000 g for each wash. 20ml antibody was diluted into 500 mL PBS buffer and mixed with washed beads followed by gentle rotation overnight at 4 C. Beads were washed once with PBS buffer followed by cross-linking as follows. Freshly prepared 13mg/ml Dimethyl pimelimidate (DMP) was mixed equally with wash buffer (0.2M triethanolamine in PBS), and 500 mL mixture was added into beads followed by rotation for 30min at room temperature. After DMP incubation, beads were washed in 1ml wash buffer by rotating for 5min followed by centrifugation. DMP incubations and bead washes were repeated twice followed by the addition of 500 mL quench buffer (50mM ethanol amine in PBS) to beads and rotation for 5 min at room temperature. Quenching reactions were repeated and beads were then washed in PBS buffer. Finally, beads were washed with 1M glycine (pH3.0) twice to remove unlinked antibody. Crossed-linked Beads were then equilibrated with NP-40 lysis buffer and used for co-IP as described above, with the exception of elution where the complex was eluted from beads with 30 mL 0.1M glycine, pH2.5 with gentle agitation followed with low-speed centrifugation. Elution was repeated and the eluates were pooled. Eluates were immediately neutralized with equal volume of 1M Tris buffer, pH8.0. IP samples were resolved using 10% Tris-glycine SDS-PAGE followed by silver staining of gels. Briefly, gels were soaked for 10 min periods with intervening washes first in 50% methanol, then in 5% methanol/30mM DTT/0.01%(w/v) AgNO 3 and then visualized using 3%(w/v) Na 2 CO 3 .
Mass Spectrometry
Following silver staining, bands of interest were cut from the gel and reduced in 10mM of DTT/100mM Ammonium bicarbonate for 30min at 37 C and 30min at 56 C. The DTT solution was then replaced with the same volume of 50mM iodoacetamide/ 100mM NH 4 HCO 3 after cooling to room temperature. After 45min incubation at room temperature in the dark, gel pieces were washed for 10 min with 100mM NH 4 HCO 3 and dehydrated with the addition of acetonitrile. The pieces were rehydrated with addition of 100mM NH 4 HCO 3 . After removing excess NH 4 HCO 3 , gel pieces were dried completely via the Refrigerated CentriVap Centrifugal Concentrator (Labconco). The dried gel slices were submerged in 12.5ng/mL trypsin (Pierce)/50mM NH 4 HCO 3 at 4 C for 45min. The pieces were topped off with 20 mL of 50mM NH 4 HCO 3 and incubated at 37 C overnight. The mixture was spun down, supernatant collected and gel pieces were subject to extraction with 25 mL of 5% formic acid in 50% acetonitrile for 20 min at room temperature three times. The collected supernatant was dried via CentriVap.
The dried sample was then brought to solution in 0.5% TFA and was applied to Pierce C18 spin column (Thermo Scientific), dried, dissolved in 20 mL of Buffer A (94.875% H 2 O, 5% ACN, 0.125% FA) and quantified with microBCA Protein Assay (Pierce). 6 mg of sample was loaded onto a vented Acclaim Pepmap 100, 75 mm x 2cm nanoViper trap column and eluted from nanoViper analytical column with increasing Buffer B (99.875% ACN, 0.125% FA) concentration using Thermo EASY nLC 1000 UPLC pump. The eluted peptides were electrosprayed from the stainless-steel emitter tip on the Nanospray Flex Ion Source and analyzed by the Orbitrap Fusion Tribid mass spectrometer. MS parameters were as follows: ion transfer tube temp = 300 C, Easy-IC internal mass calibration, default charge state = 2, detector type set to Orbitrap, with 60K resolution. Wide quad isolation, mass range = normal, scan range = 300-1500 m/z and max injection time = 50 ms. AGC target = 200,000, microscans = 1, S-lens RF level = 60 and without source
